Exollence

Exollence is a biotechnology company specializing in the development of next-generation exosome-based therapeutic delivery systems. The company leverages its proprietary platform to engineer exosomes for the targeted delivery of diverse payloads, including mRNA, proteins, and small molecules. By utilizing the natural properties of exosomes, Exollence aims to overcome traditional delivery barriers, particularly for genetic medicines and oncology treatments. The firm is focused on advancing its pipeline through pre-clinical development while establishing strategic partnerships for its delivery technology. Headquartered in Suzhou, China, Exollence is positioned at the forefront of the emerging exosome therapeutics sector.